•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A05412 Summary:

BILL NOA05412A
 
SAME ASNo Same As
 
SPONSORZinerman
 
COSPNSR
 
MLTSPNSR
 
Add §267-c, Pub Health L
 
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Go to top

A05412 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5412--A
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                    February 13, 2025
                                       ___________
 
        Introduced by M. of A. ZINERMAN -- read once and referred to the Commit-
          tee  on Health -- recommitted to the Committee on Health in accordance
          with Assembly Rule 3, sec. 2 -- committee  discharged,  bill  amended,
          ordered reprinted as amended and recommitted to said committee
 
        AN  ACT  to  amend  the  public health law, in relation to the statewide
          fibroid study program
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new section
     2  267-c to read as follows:
     3    § 267-c. Statewide  fibroid  study  program.  The  commissioner  shall
     4  establish  within  the  department  a  statewide  fibroid  study program
     5  through which the department will study and evaluate the  occurrence  of
     6  fibroids  and  the  alleviation  of  pain  caused  by these tumors. This
     7  program shall:
     8    (a) examine and evaluate current research and progress in the study of
     9  fibroids;
    10    (b) examine and evaluate current treatment methods for fibroids;
    11    (c) identify potential barriers to access to treatment for fibroids;
    12    (d) examine the symptoms and effects of fibroids on women of color;
    13    (e) identify  any  potential  barriers  to  access  to  treatment  for
    14  fibroids,  in  addition to barriers identified pursuant to paragraph (h)
    15  of this subdivision, for women of color;
    16    (f) make recommendations as the development of treatment  methods  for
    17  fibroids;
    18    (g) make recommendations to remove any potential barriers to access to
    19  treatment of fibroids; and
    20    (h) make recommendations to remove any potential barriers to access to
    21  treatment of fibroids specific to potential barriers to access to treat-
    22  ment faced by women of color.
    23    §  2.  This  act  shall take effect on the sixtieth day after it shall
    24  have become a law.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08100-02-6
Go to top